Mitchell L. Krassan
2019
In 2019, Mitchell L. Krassan earned a total compensation of $1M as Chief Strategy Performance Officer at TherapeuticsMD, a 7% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $180,000 |
|---|---|
| Option Awards | $484,467 |
| Salary | $360,000 |
| Other | $20,527 |
| Total | $1,044,994 |
Krassan received $484.5K in option awards, accounting for 46% of the total pay in 2019.
Krassan also received $180K in non-equity incentive plan, $360K in salary and $20.5K in other compensation.
Rankings
In 2019, Mitchell L. Krassan's compensation ranked 9,092nd out of 13,971 executives tracked by ExecPay. In other words, Krassan earned more than 34.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,092 out of 13,971 | 35th |
Division Manufacturing | 3,647 out of 5,701 | 36th |
Major group Chemicals And Allied Products | 1,379 out of 2,200 | 37th |
Industry group Drugs | 1,176 out of 1,886 | 38th |
Industry Pharmaceutical Preparations | 871 out of 1,398 | 38th |
Pay ratio
| Mitchell L. Krassan's Pay | $1,044,994 |
|---|---|
| Median Employee's Pay | $114,000 |
| Pay Ratio | 9to 1 |
In 2019, the annual total compensation of Mitchell L. Krassan was $1,044,994.
The annual total compensation of the median employee at TherapeuticsMD was $114,000.
The ratio of Mitchell L. Krassan's pay to the pay of median employee was therefore 9 to one.
Source: SEC filing on May 4, 2020.
Krassan's colleagues
We found four more compensation records of executives who worked with Mitchell L. Krassan at TherapeuticsMD in 2019.